|
Past Events
|
Following the success of the first PEP workshop in 2012 September, the second Putting Evidence into Practice (PEP) workshop was focusing on implementation of the newly adopted and Europeanized guidelines particularly in the Central and Eastern European context.
To see the Workshop Report please click here.
For the final programme and list of participants please click here.
|
|
Past Events
|
The Irish Cancer Society in partnership with the Association of European Cancer Leagues, hosted the Official Conference for the European Week Against Cancer in the Aviva stadium Dublin on May 29-30, 2013.
(Source: http://www.cancer.ie/about-us/events/european-week-against-cancer-conference)
This conference brought together some of the most noted speakers on international health and public policy that can reduce the risk of cancer. The theme for the conference was Healthy Lifestyles for Cancer Prevention (Day 1) and Tobacco Control (Day 2). Click on the links below for more information.
|
|
Past Events
|
Project Team Meeting CWA 68 Quality criteria for health checks was held on 8 February 2013 in Madurodam, The Hague, the Netherlands.
Click to see the Meeting Minutes, Presentations and Resolution of Comments.
|
|
Past Events
|
The Irish Cancer Society in partnership with the Association of European Cancer Leagues, will host the Official Conference for the European Week Against Cancer in the Aviva stadium Dublin on May 29-30, 2013.
The conference is an associated event of the Irish Presidency of the Council of the EU and will be officially opened by the Irish Minister for Health Dr. James Reilly T.D. This two day conference will bring together the best international evidence and public policies that can reduce the risk of cancer. The theme for the conference will be on Healthy Lifestyles for Cancer Prevention (Day 1) and Tobacco Control (Day 2). This conference is free to attend and will be of interest to professionals working in the area of Public Health, Cancer Prevention or Tobacco Control. Click on the links below for all the details about the Official Conference for the European Week Against Cancer.
|
|
Past Events
|
|
The French National Cancer Institute (INCa) organized a high-level meeting within the frame of the European Partnership for Actions Against Cancer
This conference held on October 18 and 19, 2012 at the Cité Internationale Universitaire de Paris, addressed European coordination of research. Main public and private stakeholders of cancer research from 17 European countries attended the meeting that aimed at presenting new coordinated actions to impact European cancer research. Concrete, ambitious and innovating projects as well as new organisational models were discussed. INCa presented a potential CLIP² - like organisation to be developed at European level; this INCa project sponsors at national level, early-phase clinical trials for innovative drugs and is conducted with the pharma industry. Driven by the Italian partners, a second pilot project on the development of a platform dedicated to outcome research was discussed. A third potential pilot project on research prevention was presented by the Spanish partners. The European Partnership for Actions Against Cancer supports the EU member States for a better coordination of cancer activities and is structured around 4 main areas: health promotion and early detection, dissemination of good practices in cancer healthcare, cooperation and coordination in cancer research, and comparable information and data. INCa is an active member of the Partnership and co-leads the work package on "research coordination"
To see the Meeting Documents please click on the links below:
The Programme of the Meeting
The Final Report of the Meeting
The Biographies of the speakers and panelists
To see presentations presented at the Meeting please click on the links bellow:
18 OCTOBER 2012
Introduction / Purpose & expectations
Agnès Buzyn, President, Institut National du Cancer, Co-leader EPAAC WP8
Julio E. Celis, ECCO Policy Committee, Danish Cancer Society,Leader EPAAC WP8
Pilot Project 1: Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
Fabien Calvo, Deputy Director General, Institut National du Cancer: Overview on the implementation of the CLIP² program & the public-private partnership in early stages clinical trials in France: key steps and pre-requisites
Panel discussion
Examples of similar public-private partnership in other European countries / Chairs: Jane Cope, NCRI (UK) and Fabien Calvo, INCa (FR)
In the UK, Matthew Seymour, Director of the National Cancer Research Network
In Spain, Alejandro Piris, scientific manager, Vall d'Hebron Institute of Oncology
In Italy, Marco Pierotti, Scientific Director, Fondazione Istituto Nazionale dei Tumori, Milan
Pilot Project 1: review of key steps & pre-requisites
Panel discussion
Designation of the early phase clinical centres / Chairs: Kate Miller, ECMC network, UK and Philippe Cassier, Coordinator CLIP² Léon Bérard, Lyon
Introduction
Example in France, Philippe Cassier
In the UK, Kate Miller
Interface with biology infrastructures, Frédérique Nowak, Head of the innovation at INCa (FR)
A European approach – Possible way forwards and interactions, ECRIN (European clinical research infrastructure network), Jacques Demotes, programme coordinator at ECRIN
EATRIS (European Advanced Translational Research Infrastructure), Giovanni Migliaccio, EATRIS Scientific Director & Istituto Superiore di Sanità, Italy
OECI & BenchCan, Wim van Harten, President, Organisation of European Cancer Institutes
Panel discussion
Funding models and organisation of the calls for proposals / Chairs: Nadine Houédé, Oncology Centre Bergonié (France) and Erica Hackenitz, ZonMW (The Netherlands)
Introduction by N. Houédé and E. Hackenitz
Merel Hoozemans - Strik, Research coordinator, KWF Kankerbestrijding, NL
Béatrice Bussière, INCa
Michael Warmbold – VP Medical Affairs Oncology Europe, Pfizer
Jérôme Boichot, GE Healthcare
19 OCTOBER 2012
Pilot Project 2: a European platform for outcomes research - Review of experiences & pre-requisites
Overview of needs, challenges and opportunities, Maria Ferrantini, Ministry of Health, Italy - Istituto Superiore di Sanità
Panel discussion
Key issues for optimizing data collection and use / Chair: Franco Berrino, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy)
EUROCARE High Resolution studies, Jean Faivre, Burgundy Digestive Cancer Registry, INSERM U866, University of Burgundy, University Hospital of Dijon (France)
Dutch studies linking registries' and clinical data, Jan Willem Coebergh, EUROCOURSE Coordinator, International Benchmark Study
Michel P. Coleman, Cancer Research UK Cancer Survival Group, (United Kingdom)
Pilot Project 2: a European platform for outcomes research – Need and feasibility
Panel discussion
Is the building of a cancer information system needed and feasible in Europe? Chair: Herman Brenner, German Cancer Research Center
Cancer information and public health, Tit Albreht, National Institute of Public Health of Slovenia (Slovenia)
The EPAAC WP9 proposal of a European Cancer Information System (ECIS), Riccardo Capocaccia, Istituto Superiore di Sanità (Italy)
Panel discussion
Cancer outcomes research: where to start from? Chairs: Ulrik Ringborg, EurocanPlatform Coordinator and Marco Pierotti, Scientific Director, Fondazione Istituto Nazionale dei Tumori, Milan (Italy)
Outcomes research and clinical epidemiology in the EurocanPlatform project , Herman Brenner, German Cancer Research Center
Clinical validation of biomarkers in archive tissues by multicentric studies Giorgio Stanta, chairman of the OECI Biobanks and Molecular Pathobiology Working Group
Population data and clinical outcome research: opportunities and challenges, Milena Sant, EPAAC WP9 leader, Descriptive studies and health planning unit, Istituto nazionale tumori, Milano, Italy
Presentation of a potential Pilot Project 3: Prevention Carlos Segovia Perez, Instituto de Salud Carlos III, & Rosana Peiro, Centro Superior de Investigacion en Salud Publica, Spain
|
|
Past Events
|
The third regional workshop of EPAAC WP6 [early diagnosis & screening] will be taking place on 3-4 june 2013.
The workshop will take place at the Brussles Royal Academy, Belgium.
The focus of the workshop will be on implementing breast cancer screening programmes.
To register your interest in participating, or for further information, please contact Sol Wallyn:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
.
|
|
Past Events
|
|
The next Steering Committee meeting will be taking place in Malta from 13-15 May 2013. On 14 May, there will be meetings of the Working Group on National Cancer Plans and Advisory Committee, on 15 May will follow a meeting of the Steering Committee. More information on agendas will be posted as becomes available.
|
|
Past Events
|
We are pleased to make available the meeting agenda and the report for the meeting on 8 to 9 November 2012 on the Psychosocial Oncology Action within EPAAC Work Package 7, Healthcare. The meeting discussed the development of a training programme on communication skills and psychosocial care for European countries with low resources in this area. This action is being carried out by EPAAC Work Package 7 with the help and input of the International Psycho-oncology Society (IPOS).
The Meeting Agenda and Report are available.
|
|
Past Events
|
EPAAC is proud to have been invited to present at the World Cancer Congress organised by the UICC between 27 and 30 August 2012at the Palais des Congrès Montréal, Canada. A large number of participants registered for the event that represents a unique and ideal platform for the international cancer control community to meet, discuss, share, learn and connect in order to find solutions to reduce the impact of cancer on communities around the world. On this occasion, Dr. Tit Albreht, Leader of the National Cancer Plans Work Package, presented EPAAC.
To see the EPAAC presentation, please click here.
This year's theme for the congress was "Connecting for Global Impact" highlighting the need for continued support and momentum in translating the benefits of knowledge gained through research and practice to those living with and affected by cancer.
To find out more about the World Cancer Congress, please click here.
|
|
|
